Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review

International Journal of Dermatology
Maria GanevaValentina Tzaneva

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but severe drug reaction, most commonly to aromatic anticonvulsants with a delayed onset, variable clinical presentation and protracted course. The exact incidence of DRESS syndrome is not known because of the variability in clinical presentation, lack of strict diagnostic criteria and universally accepted nomenclature. We report four cases of DRESS syndrome associated with the use of carbamazepine. The clinical manifestation was similar: a maculopapular eruption progressing to exfoliative erythroderma, fever, and lymphadenopathy. Leukocytosis, atypical lymphocytes and liver injury (in 2 patients) were also observed. Assessment of causality using the Naranjo algorithm established a "probable" relationship with carbamazepine in three of the cases and a "possible" relationship in one case. Detection of DRESS syndrome is dependent on the exclusion of a variety of diseases with similar manifestations and may be delayed in time. DRESS syndrome is a potentially life-threatening multisystem adverse drug reaction, and accidental reexposure or drug provocation tests must be avoided.

References

Nov 1, 1979·Neurology·F Haruda
Dec 1, 1992·Seminars in Neurology·D K Chang, N H Shear
Mar 1, 1989·Medical Toxicology and Adverse Drug Experience·L DurelliR Cavallo
Oct 28, 1988·Deutsche medizinische Wochenschrift·G FedermannP A Berg
Jan 1, 1987·Epilepsia·J M Pellock
Apr 1, 1988·Journal of the American Academy of Dermatology·A K SilvermanR C Wong
Dec 1, 1988·The Journal of Clinical Investigation·N H Shear, S P Spielberg
Apr 1, 1988·Veterinary and Human Toxicology·R D Kimbrough
Aug 1, 1986·Annals of Internal Medicine·N H ShearW Kalow
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Jan 1, 1993·Dermatology : International Journal for Clinical and Investigative Dermatology·J M Bonnetblanc
Aug 1, 1996·Journal of the American Academy of Dermatology·R Prussick, N H Shear
Dec 1, 1996·Seminars in Cutaneous Medicine and Surgery·L E Shapiro, N H Shear
Jun 16, 1999·The Annals of Pharmacotherapy·E MylonakisS Rounds
Nov 24, 1999·Postgraduate Medical Journal·U MahadevaE Leen
Jun 26, 2001·The British Journal of Dermatology·M AiharaZ Ikezawa
Jun 6, 2003·The British Journal of Dermatology·V DescampsB Crickx
Jun 6, 2003·The Journal of Allergy and Clinical Immunology·Dean J NaisbittB Kevin Park
Jul 23, 2003·Journal of Psychopharmacology·G M Goodwin, UNKNOWN Consensus Group of the British Association for Psychopharmacology
Dec 25, 2003·International Journal of Dermatology·Julia ValencakWolfgang Base
Sep 4, 2004·British Journal of Pharmacology·John L Wallace
Jun 8, 1950·The New England Journal of Medicine·B H CHAIKENJ P SEGAL
Jun 30, 2005·International Journal of Dermatology·A KaminskyC Kien
Nov 1, 2006·Allergology International : Official Journal of the Japanese Society of Allergology·Tetsuo ShioharaYoko Kano
Dec 15, 2006·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Cornelia S SeitzAxel Trautmann
May 1, 1995·Indian Journal of Dermatology, Venereology and Leprology·C Balachandran

❮ Previous
Next ❯

Citations

Aug 21, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S StänderT Schwarz
Jul 3, 2009·The Journal of Antimicrobial Chemotherapy·Philippa HorsfieldRichard Ellis
Jul 9, 2011·Pharmacogenetics and Genomics·Caroline F ThornRuss B Altman
Oct 22, 2009·AJR. American Journal of Roentgenology·Alexander SauterMarius Horger
Feb 28, 2014·The New England Journal of Medicine·Amir T FathiRobert P Hasserjian
Oct 9, 2013·Psychosomatics·Mario V MitkovJason P Caplan
Feb 1, 2011·Archivos de la Sociedad Española de Oftalmología·J Gros-OteroJ Benítez-Herreros
Apr 11, 2013·Clinics in Geriatric Medicine·Ammar M AhmedJason Reichenberg
Dec 3, 2011·General Hospital Psychiatry·Karim SedkySteven Lippmann
Jul 19, 2011·General Hospital Psychiatry·Drieske A HalinkRichard C Oude Voshaar
Dec 24, 2010·Thérapie·Amel ChaabaneNaceur A Boughattas
Aug 12, 2009·Journal of the American Academy of Dermatology·Kerry K ShaughnessyKimberly S Salkey
Aug 20, 2009·Bipolar Disorders·Felicity NgUNKNOWN International Society for Bipolar Disorders
Mar 16, 2013·International Journal of Laboratory Hematology·N SavageJ Gotlib
Jan 30, 2014·The Journal of Dermatology·Kyoko KannoHajime Iizuka
Jul 20, 2013·The Australasian Journal of Dermatology·Suran L Fernando
May 20, 2011·The American Journal of Medicine·Patrice CacoubJean Claude Roujeau
Apr 23, 2013·Journal of the American Academy of Dermatology·Zain HusainRobert A Schwartz
Dec 3, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Gregory M Cowan, Richard F Lockey
Apr 30, 2016·Mayo Clinic Proceedings·Tanner J BommersbachSimon Kung
Aug 5, 2016·International Journal of Molecular Sciences·Hueng-Chuen FanChing-Shiang Chi
Aug 24, 2017·BMJ Case Reports·Muhammad RiazGaurav Nigam
Oct 13, 2017·The Annals of Pharmacotherapy·P Brittany VickeryAlicia Potter DeFalco
Mar 5, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Christina E Brizendine, Paras J Naik
Apr 3, 2020·Drug and Therapeutics Bulletin·Catarina LameirasMaria do Céu Dória
Sep 24, 2020·Case Reports in Pediatrics·S VithanaG P Hewawitharana
Nov 23, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Olivier MathieuDominique Hillaire-Buys
Oct 28, 2019·BMJ Case Reports·Catarina LameirasMaria do Céu Dória
Jun 11, 2011·International Journal of Immunopathology and Pharmacology·A ScaparrottaF Chiarelli
Feb 20, 2018·Experimental and Therapeutic Medicine·Can ChenShenxian Qian
Jan 19, 2021·BJA Education·B ScraceC Bigham
Sep 13, 2019·American Journal of Therapeutics·Şakir GicaNesrin Karamustafalioglu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.